187 related articles for article (PubMed ID: 37305402)
21. Prognostic value of epithelial-mesenchymal transition markers in clear cell renal cell carcinoma.
Xu H; Xu WH; Ren F; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW
Aging (Albany NY); 2020 Jan; 12(1):866-883. PubMed ID: 31915310
[TBL] [Abstract][Full Text] [Related]
22. An epithelial-mesenchymal transition-related mRNA signature associated with the prognosis, immune infiltration and therapeutic response of colon adenocarcinoma.
Zhang Y; Li Y; Zuo Z; Li T; An Y; Zhang W
Pathol Oncol Res; 2023; 29():1611016. PubMed ID: 36910014
[No Abstract] [Full Text] [Related]
23. Genomics and prognosis analysis of epithelial-mesenchymal transition in colorectal cancer patients.
Zhang Z; Zheng S; Lin Y; Sun J; Ding N; Chen J; Zhong J; Shi L; Xue M
BMC Cancer; 2020 Nov; 20(1):1135. PubMed ID: 33228590
[TBL] [Abstract][Full Text] [Related]
24. Establishing a Prognostic Signature Based on Epithelial-Mesenchymal Transition-Related Genes for Endometrial Cancer Patients.
Liu J; Cui G; Shen S; Gao F; Zhu H; Xu Y
Front Immunol; 2021; 12():805883. PubMed ID: 35095892
[TBL] [Abstract][Full Text] [Related]
25. Identification and validation of CALCRL-associated prognostic genes in acute myeloid leukemia.
Huang Z; Zhang H; Xing C; Zhang L; Zhu H; Deng Z; Yin L; Dong E; Wang C; Peng H
Gene; 2022 Jan; 809():146009. PubMed ID: 34655717
[TBL] [Abstract][Full Text] [Related]
26. Reduced protocadherin17 expression in leukemia stem cells: the clinical and biological effect in acute myeloid leukemia.
Xu ZJ; Ma JC; Zhou JD; Wen XM; Yao DM; Zhang W; Ji RB; Wu DH; Tang LJ; Deng ZQ; Qian J; Lin J
J Transl Med; 2019 Mar; 17(1):102. PubMed ID: 30922328
[TBL] [Abstract][Full Text] [Related]
27. Construction and validation of a novel signature based on epithelial-mesenchymal transition-related genes to predict prognosis and immunotherapy response in hepatocellular carcinoma by comprehensive analysis of the tumor microenvironment.
Gao B; Wang Y; Lu S
Funct Integr Genomics; 2022 Dec; 23(1):6. PubMed ID: 36536232
[TBL] [Abstract][Full Text] [Related]
28. Integrated analysis of single-cell RNA-seq and bulk RNA-seq reveals RNA N6-methyladenosine modification associated with prognosis and drug resistance in acute myeloid leukemia.
Li Z; Liu X; Wang L; Zhao H; Wang S; Yu G; Wu D; Chu J; Han J
Front Immunol; 2023; 14():1281687. PubMed ID: 38022588
[TBL] [Abstract][Full Text] [Related]
29. High NCALD expression predicts poor prognosis of cytogenetic normal acute myeloid leukemia.
Song Y; Zhang W; He X; Liu X; Yang P; Wang J; Hu K; Liu W; Zhang X; Jing H; Yuan X
J Transl Med; 2019 May; 17(1):166. PubMed ID: 31109331
[TBL] [Abstract][Full Text] [Related]
30. MLL-AF9 Expression in Hematopoietic Stem Cells Drives a Highly Invasive AML Expressing EMT-Related Genes Linked to Poor Outcome.
Stavropoulou V; Kaspar S; Brault L; Sanders MA; Juge S; Morettini S; Tzankov A; Iacovino M; Lau IJ; Milne TA; Royo H; Kyba M; Valk PJM; Peters AHFM; Schwaller J
Cancer Cell; 2016 Jul; 30(1):43-58. PubMed ID: 27344946
[TBL] [Abstract][Full Text] [Related]
31. A Novel Defined Pyroptosis-Related Gene Signature for the Prognosis of Acute Myeloid Leukemia.
Huang K; Xie L; Wang F
Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553549
[TBL] [Abstract][Full Text] [Related]
32. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B
J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606
[TBL] [Abstract][Full Text] [Related]
33. Upregulated mitosis-associated genes CENPE, CENPF, and DLGAP5 predict poor prognosis and chemotherapy resistance of Acute Myeloid Leukemia.
Shi M; Guo H; Bai Y; Niu J; Niu X; Sun K; Chen Y
Cancer Biomark; 2022; 35(1):11-25. PubMed ID: 35634845
[TBL] [Abstract][Full Text] [Related]
34. Prognostic prediction and immune infiltration analysis based on ferroptosis and EMT state in hepatocellular carcinoma.
Liu Z; Wang J; Li S; Li L; Li L; Li D; Guo H; Gao D; Liu S; Ruan C; Dang X
Front Immunol; 2022; 13():1076045. PubMed ID: 36591279
[TBL] [Abstract][Full Text] [Related]
35. The clinical and biological characterization of acute myeloid leukemia patients with S100A4 overexpression.
Yao CY; Lin CC; Wang YH; Hsu CL; Kao CJ; Hou HA; Chou WC; Tien HF
J Formos Med Assoc; 2023 Jul; 122(7):636-647. PubMed ID: 36428148
[TBL] [Abstract][Full Text] [Related]
36. Identification of prognostic genes in the acute myeloid leukemia microenvironment.
Huang S; Zhang B; Fan W; Zhao Q; Yang L; Xin W; Fu D
Aging (Albany NY); 2019 Nov; 11(22):10557-10580. PubMed ID: 31740623
[TBL] [Abstract][Full Text] [Related]
37. Establishment of tumor protein p53 mutation-based prognostic signatures for acute myeloid leukemia.
Xie J; Chen K; Han H; Dong Q; Wang W
Curr Res Transl Med; 2022 Sep; 70(4):103347. PubMed ID: 35483237
[TBL] [Abstract][Full Text] [Related]
38. Epithelial-mesenchymal transition-related lncRNAs associated with prognosis and immune cell infiltration in lung adenocarcinoma.
Zhang Q; Wu X; Sun Y; Yang L; Wang Z; Yang Y; Zhao X; Zhang X
Am J Transl Res; 2022; 14(10):7308-7323. PubMed ID: 36398231
[TBL] [Abstract][Full Text] [Related]
39. Establishment and validation of a carbohydrate metabolism-related gene signature for prognostic model and immune response in acute myeloid leukemia.
Yang Y; Yang Y; Liu J; Zeng Y; Guo Q; Guo J; Guo L; Lu H; Liu W
Front Immunol; 2022; 13():1038570. PubMed ID: 36544784
[TBL] [Abstract][Full Text] [Related]
40. A Prognostic Model of Seven Immune Genes to Predict Overall Survival in Childhood Acute Myeloid Leukemia.
Luo Y; Xu Y; Li X; Shi X; Huang P; Chen Y; He Z
Biomed Res Int; 2022; 2022():7724220. PubMed ID: 36518627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
